Companies similar to Immunic, Inc. (IMUX)
Health Care · Nasdaq
Immunic, Inc. (IMUX)'s closest peers include Biogen (BIIB), Bristol Myers Squibb (BMY), Merck & Co. (MRK) and AbbVie (ABBV). This peer set is drawn from IMUX's enriched company profile and is informational only — not financial advice.
Similar companies
-
BiogenBIIBHealth Care
Biogen is a global biotechnology company developing and commercializing therapies across neurology, immunology, and rare genetic disease.
$208.92 (as of 2026-07-16) · market cap $30.3B
-
Bristol Myers SquibbBMYHealth Care
A diversified biopharmaceutical company leveraging immunotherapy, cell therapies, and small-molecule platforms to address cancer, autoimmune disease, and…
$60.51 (as of 2026-07-16) · market cap $121.8B
-
Merck & Co.MRKHealth Care
Global pharmaceutical and vaccine leader with oncology, infectious disease, and animal health franchises, anchored by blockbuster immunotherapy Keytruda.
$127.63 (as of 2026-07-16) · market cap $311.9B
-
AbbVieABBVHealth Care
Global biopharmaceutical company with leadership positions in immunology, neuroscience, oncology, and aesthetics targeting complex diseases.
$254.39 (as of 2026-07-16) · market cap $431.3B
Not quite? Describe exactly what you want →
Peers are drawn from IMUX's enriched profile (the same similarity signal the chat uses for "companies like IMUX"). See the full profile: Immunic, Inc. (IMUX).
Last updated 2026-07-16.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.